Invesco Ltd. reduced its stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 54.8% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 536,803 shares of the business services provider's stock after selling 651,570 shares during the quarter. Invesco Ltd. owned about 1.06% of Exponent worth $43,513,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also recently made changes to their positions in EXPO. Whipplewood Advisors LLC raised its holdings in Exponent by 5,333.3% in the 1st quarter. Whipplewood Advisors LLC now owns 326 shares of the business services provider's stock worth $26,000 after acquiring an additional 320 shares during the last quarter. UMB Bank n.a. increased its stake in shares of Exponent by 859.1% in the 1st quarter. UMB Bank n.a. now owns 633 shares of the business services provider's stock worth $51,000 after purchasing an additional 567 shares in the last quarter. Bessemer Group Inc. increased its stake in shares of Exponent by 103.3% in the 1st quarter. Bessemer Group Inc. now owns 681 shares of the business services provider's stock worth $55,000 after purchasing an additional 346 shares in the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Exponent in the 4th quarter worth $59,000. Finally, LRI Investments LLC boosted its holdings in Exponent by 30.4% in the 4th quarter. LRI Investments LLC now owns 1,460 shares of the business services provider's stock worth $130,000 after buying an additional 340 shares during the period. 92.37% of the stock is owned by institutional investors.
Insider Activity at Exponent
In related news, VP Joseph Sala sold 1,595 shares of the business's stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of $70.64, for a total transaction of $112,670.80. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Joseph Rakow sold 1,573 shares of the business's stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $77.72, for a total transaction of $122,253.56. The disclosure for this sale can be found here. Insiders have sold a total of 8,064 shares of company stock valued at $582,981 over the last ninety days. 1.60% of the stock is owned by company insiders.
Exponent Stock Performance
Shares of EXPO traded up $2.59 during midday trading on Friday, hitting $73.07. 90,176 shares of the company traded hands, compared to its average volume of 320,574. The firm has a 50 day moving average of $72.91 and a 200-day moving average of $78.21. Exponent, Inc. has a 52 week low of $63.81 and a 52 week high of $115.75. The stock has a market cap of $3.69 billion, a price-to-earnings ratio of 36.49 and a beta of 0.89.
Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The business services provider reported $0.52 EPS for the quarter, beating analysts' consensus estimates of $0.48 by $0.04. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The firm had revenue of $132.87 million during the quarter, compared to the consensus estimate of $130.82 million. During the same quarter last year, the firm earned $0.57 EPS. The firm's revenue for the quarter was up 7.3% compared to the same quarter last year. Sell-side analysts predict that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.
Exponent Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 19th. Investors of record on Friday, September 5th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.6%. The ex-dividend date of this dividend is Friday, September 5th. Exponent's dividend payout ratio (DPR) is presently 60.00%.
Exponent Company Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.